UC San Diego Health treats 1st cancer patient with stem-cell derived natural killer cells

(University of California - San Diego) Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news